Abstract
A method to prepare thymidine phosphorodithioate dimers (ref. 1) has been extended to allow the preparation of oligo-2'-deoxyribonucleotide phosphorodithioates containing all four bases. The method is suitable for large-scale synthesis and gives phosphorodithioates without phosphorothioate impurities (31P nmr, detection limit 0.5 to 1%). Oligonucleotides up to octamers which contain -0-(PS2-)-0- linkages at all positions have been prepared by block synthesis in solution. The phosphorodithioate linkage is introduced by the reaction of a 5'-O, N-protected nucleoside (or oligonucleotide) with a dithiophosphorylating agent RSP(S)(ODhbt)2, R = 2,4-dichlorobenzyl, Dhbt = 3,4-dihydro-4-oxo-benzotriazin-3-yl, followed by coupling of the product to a 3'-O,N-protected nucleoside (or oligonucleotide). This method gives pure protected oligodeoxyribonucleoside phosphorodithioates, and phosphorothioate linkages are only introduced if contact with conc. aqueous ammonia during or after deblocking is unduly prolonged.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bjergårde K., Dahl O. Solid phase synthesis of oligodeoxyribonucleoside phosphorodithioates from thiophosphoramidites. Nucleic Acids Res. 1991 Nov 11;19(21):5843–5850. doi: 10.1093/nar/19.21.5843. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ghosh M. K., Ghosh K., Dahl O., Cohen J. S. Evaluation of some properties of a phosphorodithioate oligodeoxyribonucleotide for antisense application. Nucleic Acids Res. 1993 Dec 11;21(24):5761–5766. doi: 10.1093/nar/21.24.5761. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gryaznov S. M., Letsinger R. L. Synthesis and properties of oligonucleotides containing aminodeoxythymidine units. Nucleic Acids Res. 1992 Jul 11;20(13):3403–3409. doi: 10.1093/nar/20.13.3403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marshall W. S., Beaton G., Stein C. A., Matsukura M., Caruthers M. H. Inhibition of human immunodeficiency virus activity by phosphorodithioate oligodeoxycytidine. Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6265–6269. doi: 10.1073/pnas.89.14.6265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marshall W. S., Caruthers M. H. Phosphorodithioate DNA as a potential therapeutic drug. Science. 1993 Mar 12;259(5101):1564–1570. doi: 10.1126/science.7681216. [DOI] [PubMed] [Google Scholar]
- Murata T., Iwai S., Ohtsuka E. Synthesis and characterization of a substrate for T4 endonuclease V containing a phosphorodithioate linkage at the thymine dimer site. Nucleic Acids Res. 1990 Dec 25;18(24):7279–7286. doi: 10.1093/nar/18.24.7279. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reese C. B., Stewart J. C., van Boom J. H., de Leeuw H. P., Nagel J., de Rooy J. F. The synthesis of oligoribonucleotides. Part XI. Preparation of ribonucleoside 2'-acetal 3'-esters by selective deacylation. J Chem Soc Perkin 1. 1975;(10):934–942. doi: 10.1039/p19750000934. [DOI] [PubMed] [Google Scholar]